Evidence for novel non-angiogenic pathway in breast-cancer metastasis

Lancet

Volumn 355, Issue 9217, 2000, Pages 1787-1788

  Pezzella, F ^a   Manzotti, M ^a   Di Bacco, A ^a   Viale, G ^a   Nicholson, A G ^a   Price, R ^a   Ratcliffe, C ^a   Pastorino, U ^a   Gatter, K C ^a   Harris, A L ^a   Altman, D G ^a   Pilotti, S ^a   Veronesi, U ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN;

ANGIOGENESIS; ARTICLE; BREAST CANCER; CANCER GROWTH; ENDOTHELIUM CELL; HUMAN; LUNG METASTASIS; LYMPH NODE METASTASIS; LYMPHOID TISSUE; MAJOR CLINICAL STUDY; MICROVASCULATURE; PRIORITY JOURNAL; VASCULARIZATION;

EID: 0034690655     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)02268-6     Document Type: Article

References (5)

1. Pezzella F., Pastorino U., Tagliabue E.et al. Non-small cell lung carcinoma tumour growth without neo angiogenesis. Am J Path. 151:1997;1417-1423.
2. Holash J., Maisonpierre P.C., Compton D.et al. Vessels co-option, regression, and growth in tumours mediated by angiopoietins and VEGF. Science. 284:1999;1994-1998.
3. Maniotis A.J., Folberg R., Hess A.et al. Vascular channel formation by human melanoma cells in-vivo and in-vitro. vasculogenic mimicry Am J Pathol. 155:1999;739-752.
4. Hori K., Li H.-C., Saito S., Sato Y. Increased growth and incidence of lymph node metastases due to the angiogenesis inhibitor AGM-1470. Br J Cancer. 75:1997;1730-1734.
5. Holmegren L., O'Reilly M.S., Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med. 1:1995;149-153.